• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Can the evolution of male contraception lead to a revolution? Review of the current state of knowledge.男性避孕方法的演变能否引发一场革命?当前知识状况综述。
Cent European J Urol. 2018;71(1):108-113. doi: 10.5173/ceju.2017.1450. Epub 2017 Dec 29.
2
Canadian Contraception Consensus (Part 2 of 4).加拿大避孕共识(共四部分,第二部分)
J Obstet Gynaecol Can. 2015 Nov;37(11):1033-9. doi: 10.1016/s1701-2163(16)30054-8.
3
Canadian Contraception Consensus (Part 1 of 4).加拿大避孕共识(共4部分,第1部分)
J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0.
4
Hormonal male contraception: progress and prospects for the 21st century.激素男性避孕:21世纪的进展与前景
Aust N Z J Med. 1995 Dec;25(6):808-16. doi: 10.1111/j.1445-5994.1995.tb02885.x.
5
Current status and future perspectives in male contraception.男性避孕的现状与未来展望
Minerva Ginecol. 2007 Jun;59(3):299-310.
6
How close are we in achieving safe, affordable and reversible male contraceptives?我们距离实现安全、可负担且可逆的男性避孕方法还有多远?
Endocr Metab Immune Disord Drug Targets. 2010 Jun;10(2):179-87. doi: 10.2174/187153010791213065.
7
Male contraception.男性避孕
Baillieres Clin Obstet Gynaecol. 1996 Apr;10(1):1-23. doi: 10.1016/s0950-3552(96)80059-9.
8
Advances in non-hormonal male contraception targeting sperm motility.针对精子活力的非激素男性避孕方法的进展。
Hum Reprod Update. 2023 Sep 5;29(5):545-569. doi: 10.1093/humupd/dmad008.
9
Male fertility regulation: the challenges for the year 2000.男性生育调节:2000年面临的挑战。
Br Med Bull. 1993 Jan;49(1):210-21. doi: 10.1093/oxfordjournals.bmb.a072599.
10
Male Contraception男性避孕

本文引用的文献

1
Post-vasectomy pain syndrome: diagnosis, management and treatment options.输精管切除术后疼痛综合征:诊断、管理及治疗选择
Transl Androl Urol. 2017 May;6(Suppl 1):S44-S47. doi: 10.21037/tau.2017.05.33.
2
The Association Between Vasectomy and Prostate Cancer: A Systematic Review and Meta-analysis.输精管结扎术与前列腺癌之间的关联:一项系统评价与荟萃分析
JAMA Intern Med. 2017 Sep 1;177(9):1273-1286. doi: 10.1001/jamainternmed.2017.2791.
3
Current Contraceptive Use and Variation by Selected Characteristics Among Women Aged 15-44: United States, 2011-2013.2011 - 2013年美国15 - 44岁女性当前的避孕措施使用情况及按选定特征划分的差异
Natl Health Stat Report. 2015 Nov 10(86):1-14.
4
Vasectomy: AUA guideline.输精管切除术:AUA 指南。
J Urol. 2012 Dec;188(6 Suppl):2482-91. doi: 10.1016/j.juro.2012.09.080. Epub 2012 Oct 24.
5
A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.一种新的睾酮和内固醇经皮凝胶组合,用于男性激素避孕。
J Clin Endocrinol Metab. 2012 Oct;97(10):3476-86. doi: 10.1210/jc.2012-1384. Epub 2012 Jul 12.
6
Are sexual problems more common in men who have had a vasectomy? A population-based study of Australian men.男性进行输精管结扎术后是否更常出现性功能问题?一项基于人群的澳大利亚男性研究。
J Sex Med. 2010 Feb;7(2 Pt 1):736-42. doi: 10.1111/j.1743-6109.2009.01565.x. Epub 2009 Oct 29.
7
TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN.脂溶性维生素缺乏后的组织变化。
J Exp Med. 1925 Nov 30;42(6):753-77. doi: 10.1084/jem.42.6.753.
8
Progress and prospects in male hormonal contraception.男性激素避孕的进展与前景
Curr Opin Endocrinol Diabetes Obes. 2008 Jun;15(3):255-60. doi: 10.1097/MED.0b013e3282fcc30d.
9
Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.睾酮凝胶联合醋酸甲羟孕酮是一种有效的男性激素避孕方案,添加促性腺激素释放激素(GnRH)拮抗剂并不能增强其效果。
J Clin Endocrinol Metab. 2006 Nov;91(11):4374-80. doi: 10.1210/jc.2006-1411. Epub 2006 Aug 29.
10
An implantable ligation device that achieves male sterilization without cutting the vas deferens.
Urology. 2006 Apr;67(4):807-11. doi: 10.1016/j.urology.2005.10.051. Epub 2006 Mar 29.

男性避孕方法的演变能否引发一场革命?当前知识状况综述。

Can the evolution of male contraception lead to a revolution? Review of the current state of knowledge.

作者信息

Frankiewicz Mikołaj, Połom Wojciech, Matuszewski Marcin

机构信息

Department of Urology Medical University of Gdańsk, Gdańsk, Poland.

出版信息

Cent European J Urol. 2018;71(1):108-113. doi: 10.5173/ceju.2017.1450. Epub 2017 Dec 29.

DOI:10.5173/ceju.2017.1450
PMID:29732216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5926633/
Abstract

INTRODUCTION

Great advances in medical research concerning methods of contraception have been achieved in recent years, however, more than 25% of couples worldwide still rely on condoms - a method with poor efficacy. Even though there is a spectrum of 11 different contraceptive methods for women, there are only 4 commonly used by men (condoms, periodic abstinence, withdrawal and vasectomy). In this review, advances and present, state-of-the-art, both hormonal and non-hormonal male contraceptive methods will be presented and evaluated. Potential novel targets that warrant greater research will be highlighted.

MATERIAL AND METHODS

A comprehensive literature search without a time limit was performed using the Medline database on May 2017. The terms 'male contraception' in conjunction with 'reversible inhibition of sperm under guidance' (RISUG), 'hormonal', 'non-hormonal', 'vasectomy' or 'testosterone' were used. The articles were limited to those published in English, Polish or French.

RESULTS

There are various contraceptives currently available to regulate male fertility. Vasectomy is still the most effective permanent form of male contraceptive with a failure rate lower than 1%. Reversible, non hormonal methods of male contraception, like reversible inhibition of sperm under guidance, are very promising and close to being introduced into the market. In regards to hormonal contraception research, the use of testosterone injections has been widely studied yet they often harbor undesirable side effects and require further development.

CONCLUSIONS

Despite continuous efforts worldwide, it seems that another several years of research is needed to provide safe, effective and affordable male contraceptives which will allow both men and women to participate fully in family planning.

摘要

引言

近年来,医学研究在避孕方法方面取得了巨大进展,然而,全球仍有超过25%的夫妇依赖避孕套——一种效果不佳的方法。尽管有11种不同的女性避孕方法,但男性常用的只有4种(避孕套、周期性禁欲、体外射精和输精管切除术)。在本综述中,将介绍和评估激素和非激素男性避孕方法的进展及当前的先进技术。将突出值得进一步研究的潜在新靶点。

材料与方法

2017年5月使用Medline数据库进行了无时间限制的全面文献检索。使用了“男性避孕”与“在引导下可逆抑制精子”(RISUG)、“激素”、“非激素”、“输精管切除术”或“睾酮”相结合的术语。文章仅限于以英语、波兰语或法语发表的。

结果

目前有多种避孕药可用于调节男性生育能力。输精管切除术仍然是最有效的永久性男性避孕方式,失败率低于1%。可逆的非激素男性避孕方法,如在引导下可逆抑制精子,非常有前景,且已接近推向市场。关于激素避孕研究,睾酮注射的应用已得到广泛研究,但它们往往存在不良副作用,需要进一步改进。

结论

尽管全球一直在不断努力,但似乎还需要数年的研究才能提供安全、有效且价格合理的男性避孕药,使男性和女性都能充分参与计划生育。